Development of a multi-component drug from turmeric using central composite design

作者：Zhang Xiaohang; Han Shengnan; Li Yan; Jiang Jianlan^*

来源：Frontiers of Chemical Science and Engineering, 2014, 8(3): 362-368.

DOI：10.1007/s11705-014-1439-5

• multi-component drug development
• central composite design
• turmeric
• curcuminoids

A methodology to develop multi-component drugs based on traditional Chinese medicines has been developed using central composite design. Several active components from the traditional Chinese medicine turmeric were chosen for use in a multi-component antitumor drug. Response surface methodology based on a central composite design was applied to determine the quantitative composition-activity relationships in order to optimize the amount of each component in the drug. An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to measure the pharmacological activity as the response value. The experimental antitumor activity of the optimum combination was 92.85% in the MTT assay and superior to the activities of each single component. These results demonstrate that response surface methodology based on a central composite design is suitable for the design of multi-component drugs.

• 出版日期2014-9
• 单位天津大学